Previous Close | 6.00 |
Open | 6.75 |
Bid | 6.45 |
Ask | 7.65 |
Strike | 185.00 |
Expire Date | 2025-06-20 |
Day's Range | 6.75 - 6.75 |
Contract Range | N/A |
Volume | |
Open Interest | 496 |
Shares of Teva Pharmaceutical Industries have done something unusual this year: They’ve gone up. The company’s American depositary receipt, which spent much of the past decade falling in value or stagnating at rock-bottom levels, has shot up nearly 35% this year. On Wednesday morning, executives will present the Teva’s first-quarter results, and face questions from Wall Street about whether the company can sustain this upswing.
In this article, we discuss 15 best S&P 500 dividend stocks to buy now. You can skip our detailed analysis of dividend stocks in the S&P 500 and their past performance, and go directly to read 5 Best S&P 500 Dividend Stocks To Buy Now. It’s been a dynamic first quarter for the stock market. […]
The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.